The interaction of galectin-3 with cell surface epidermal growth factor receptor (EGFR) and transforming growth factor-β receptor (TGFβR) is also believed to contribute to the increased invasiveness of tumor cells [36]. The gene discussed is EGFR; the disease is neoplasm.